Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin McFarthing

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Parkinsonism & Related Disorders|May 27, 2023
Alpha-synuclein and the Parkinson's disease drug pipelineAlberto J Espay, Kevin McFarthing
Journal of Parkinson'S Disease|August 26, 2025
What medicines do people with Parkinson's disease want?Kevin McFarthing, Tiago Fleming Outeiro, Maria Carmo Bastos
Journal of Parkinson'S Disease|May 26, 2026
Parkinson's disease drug therapies in the clinical trial pipeline: 2015-2024Susan Buff, Aleksandra Pilcicka, Kenneth Pitzer, et al.
Journal of Parkinson'S Disease|August 4, 2020
Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2020Kevin McFarthing, Sue Buff, Gary Rafaloff, et al.
Journal of Parkinson'S Disease|November 26, 2023
An International Multi-Stakeholder Delphi Survey Study on the Design of Disease Modifying Parkinson's Disease TrialsMarie-Louise Zeissler, Kevin McFarthing, Karen G Raphael, et al.
Journal of Parkinson'S Disease|June 21, 2021
Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2021 UpdateKevin McFarthing, Gary Rafaloff, Marco A S Baptista, et al.
Journal of Parkinson'S Disease|May 9, 2022
Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2022 UpdateKevin McFarthing, Gary Rafaloff, Marco Baptista, et al.
Journal of Parkinson'S Disease|June 11, 2023
Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2023 UpdateKevin McFarthing, Susan Buff, Gary Rafaloff, et al.
Journal of Parkinson'S Disease|July 20, 2024
Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2024 UpdateKevin McFarthing, Sue Buff, Gary Rafaloff, et al.
Brain : a Journal of Neurology|March 1, 2023
Towards a multi-arm multi-stage platform trial of disease modifying approaches in Parkinson's diseaseTom Foltynie, Sonia Gandhi, Cristina Gonzalez-Robles, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Parkinsonism & Related Disorders|May 27, 2023
Alpha-synuclein and the Parkinson's disease drug pipelineAlberto J Espay, Kevin McFarthing
Journal of Parkinson'S Disease|August 26, 2025
What medicines do people with Parkinson's disease want?Kevin McFarthing, Tiago Fleming Outeiro, Maria Carmo Bastos
Journal of Parkinson'S Disease|May 26, 2026
Parkinson's disease drug therapies in the clinical trial pipeline: 2015-2024Susan Buff, Aleksandra Pilcicka, Kenneth Pitzer, et al.
Journal of Parkinson'S Disease|August 4, 2020
Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2020Kevin McFarthing, Sue Buff, Gary Rafaloff, et al.
Journal of Parkinson'S Disease|November 26, 2023
An International Multi-Stakeholder Delphi Survey Study on the Design of Disease Modifying Parkinson's Disease TrialsMarie-Louise Zeissler, Kevin McFarthing, Karen G Raphael, et al.
Journal of Parkinson'S Disease|June 21, 2021
Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2021 UpdateKevin McFarthing, Gary Rafaloff, Marco A S Baptista, et al.
Journal of Parkinson'S Disease|May 9, 2022
Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2022 UpdateKevin McFarthing, Gary Rafaloff, Marco Baptista, et al.
Journal of Parkinson'S Disease|June 11, 2023
Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2023 UpdateKevin McFarthing, Susan Buff, Gary Rafaloff, et al.
Journal of Parkinson'S Disease|July 20, 2024
Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2024 UpdateKevin McFarthing, Sue Buff, Gary Rafaloff, et al.
Brain : a Journal of Neurology|March 1, 2023
Towards a multi-arm multi-stage platform trial of disease modifying approaches in Parkinson's diseaseTom Foltynie, Sonia Gandhi, Cristina Gonzalez-Robles, et al.
Pageof 2